Prevalence and drug susceptibility of clinical Candida species in nasopharyngeal cancer patients in Vietnam

In the nature, Candida species are normal inhabitants and can be observed in a wide variety of vertebrates. In humans, especially for cancer patients who fall prey to opportunistic pathogens, this group of susceptible multi-drug resistant and biofilm-forming yeasts, are among the commonest ones. In...

Full description

Saved in:
Bibliographic Details
Published in:One health Vol. 18; p. 100659
Main Authors: Nguyen, Bac V.G., Nguyen, Hau H.N., Vo, Thanh-Hoa, Le, Minh-Tri, Tran-Nguyen, Viet-Khoa, Vu, Thao Thanh, Nguyen, Phuoc-Vinh
Format: Journal Article
Language:English
Published: Netherlands Elsevier B.V 01-06-2024
Elsevier
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Abstract In the nature, Candida species are normal inhabitants and can be observed in a wide variety of vertebrates. In humans, especially for cancer patients who fall prey to opportunistic pathogens, this group of susceptible multi-drug resistant and biofilm-forming yeasts, are among the commonest ones. In this study, Candida species in 76 oral lesion samples from Vietnamese nasopharyngeal-cancer patients were isolated, morphologically identified using CHROMagar™, germ tube formation, and chlamydospore formation tests, and molecularly confirmed by PCR-RFLP. The drug susceptibility of these isolates was then tested, and the gene ERG11 was DNA sequenced to investigate the mechanism of resistance. The results showed that Candida albicans remained the most prevalent species (63.16% of the cases), followed by Candida glabrata, Candida tropicalis, and Candida krusei. The rates of resistance of non-albicans Candida for tested drugs were 85.71%, 53.57%, and 57.14% to fluconazole, clotrimazole, and miconazole, respectively. Although the drug-resistance rate of Candida albicans was lower than that of non-albicans Candida, it was higher than expected, suggesting an emerging drug-resistance phenomenon. Furthermore, ERG11 DNA sequencing revealed different mutations (especially K128T), implying the presence of multiple resistance mechanisms. Altogether, the results indicate an alarming drug-resistance situation in Candida species in Vietnamese cancer patients and emphasize the importance of species identification and their drug susceptibility prior to treatment.
AbstractList In the nature, Candida species are normal inhabitants and can be observed in a wide variety of vertebrates. In humans, especially for cancer patients who fall prey to opportunistic pathogens, this group of susceptible multi-drug resistant and biofilm-forming yeasts, are among the commonest ones. In this study, Candida species in 76 oral lesion samples from Vietnamese nasopharyngeal-cancer patients were isolated, morphologically identified using CHROMagar™, germ tube formation, and chlamydospore formation tests, and molecularly confirmed by PCR-RFLP. The drug susceptibility of these isolates was then tested, and the gene ERG11 was DNA sequenced to investigate the mechanism of resistance.The results showed that Candida albicans remained the most prevalent species (63.16% of the cases), followed by Candida glabrata, Candida tropicalis, and Candida krusei. The rates of resistance of non-albicans Candida for tested drugs were 85.71%, 53.57%, and 57.14% to fluconazole, clotrimazole, and miconazole, respectively. Although the drug-resistance rate of Candida albicans was lower than that of non-albicans Candida, it was higher than expected, suggesting an emerging drug-resistance phenomenon. Furthermore, ERG11 DNA sequencing revealed different mutations (especially K128T), implying the presence of multiple resistance mechanisms. Altogether, the results indicate an alarming drug-resistance situation in Candida species in Vietnamese cancer patients and emphasize the importance of species identification and their drug susceptibility prior to treatment.
In the nature, species are normal inhabitants and can be observed in a wide variety of vertebrates. In humans, especially for cancer patients who fall prey to opportunistic pathogens, this group of susceptible multi-drug resistant and biofilm-forming yeasts, are among the commonest ones. In this study, species in 76 oral lesion samples from Vietnamese nasopharyngeal-cancer patients were isolated, morphologically identified using CHROMagar™, germ tube formation, and chlamydospore formation tests, and molecularly confirmed by PCR-RFLP. The drug susceptibility of these isolates was then tested, and the gene was DNA sequenced to investigate the mechanism of resistance. The results showed that remained the most prevalent species (63.16% of the cases), followed by , , and . The rates of resistance of for tested drugs were 85.71%, 53.57%, and 57.14% to fluconazole, clotrimazole, and miconazole, respectively. Although the drug-resistance rate of was lower than that of , it was higher than expected, suggesting an emerging drug-resistance phenomenon. Furthermore, DNA sequencing revealed different mutations (especially K128T), implying the presence of multiple resistance mechanisms. Altogether, the results indicate an alarming drug-resistance situation in species in Vietnamese cancer patients and emphasize the importance of species identification and their drug susceptibility prior to treatment.
In the nature, Candida species are normal inhabitants and can be observed in a wide variety of vertebrates. In humans, especially for cancer patients who fall prey to opportunistic pathogens, this group of susceptible multi-drug resistant and biofilm-forming yeasts, are among the commonest ones. In this study, Candida species in 76 oral lesion samples from Vietnamese nasopharyngeal-cancer patients were isolated, morphologically identified using CHROMagar™, germ tube formation, and chlamydospore formation tests, and molecularly confirmed by PCR-RFLP. The drug susceptibility of these isolates was then tested, and the gene ERG11 was DNA sequenced to investigate the mechanism of resistance. The results showed that Candida albicans remained the most prevalent species (63.16% of the cases), followed by Candida glabrata , Candida tropicalis , and Candida krusei . The rates of resistance of non-albicans Candida for tested drugs were 85.71%, 53.57%, and 57.14% to fluconazole, clotrimazole, and miconazole, respectively. Although the drug-resistance rate of Candida albicans was lower than that of non-albicans Candida , it was higher than expected, suggesting an emerging drug-resistance phenomenon. Furthermore, ERG11 DNA sequencing revealed different mutations (especially K128T), implying the presence of multiple resistance mechanisms. Altogether, the results indicate an alarming drug-resistance situation in Candida species in Vietnamese cancer patients and emphasize the importance of species identification and their drug susceptibility prior to treatment.
In the nature, Candida species are normal inhabitants and can be observed in a wide variety of vertebrates. In humans, especially for cancer patients who fall prey to opportunistic pathogens, this group of susceptible multi-drug resistant and biofilm-forming yeasts, are among the commonest ones. In this study, Candida species in 76 oral lesion samples from Vietnamese nasopharyngeal-cancer patients were isolated, morphologically identified using CHROMagar™, germ tube formation, and chlamydospore formation tests, and molecularly confirmed by PCR-RFLP. The drug susceptibility of these isolates was then tested, and the gene ERG11 was DNA sequenced to investigate the mechanism of resistance. The results showed that Candida albicans remained the most prevalent species (63.16% of the cases), followed by Candida glabrata, Candida tropicalis, and Candida krusei. The rates of resistance of non-albicans Candida for tested drugs were 85.71%, 53.57%, and 57.14% to fluconazole, clotrimazole, and miconazole, respectively. Although the drug-resistance rate of Candida albicans was lower than that of non-albicans Candida, it was higher than expected, suggesting an emerging drug-resistance phenomenon. Furthermore, ERG11 DNA sequencing revealed different mutations (especially K128T), implying the presence of multiple resistance mechanisms. Altogether, the results indicate an alarming drug-resistance situation in Candida species in Vietnamese cancer patients and emphasize the importance of species identification and their drug susceptibility prior to treatment.
ArticleNumber 100659
Author Vo, Thanh-Hoa
Le, Minh-Tri
Nguyen, Bac V.G.
Tran-Nguyen, Viet-Khoa
Nguyen, Phuoc-Vinh
Vu, Thao Thanh
Nguyen, Hau H.N.
Author_xml – sequence: 1
  givenname: Bac V.G.
  surname: Nguyen
  fullname: Nguyen, Bac V.G.
  organization: Faculty of Pharmacy, University of Medicine and Pharmacy at Ho Chi Minh City, Ho Chi Minh City, Viet Nam
– sequence: 2
  givenname: Hau H.N.
  surname: Nguyen
  fullname: Nguyen, Hau H.N.
  organization: Faculty of Pharmacy, University of Medicine and Pharmacy at Ho Chi Minh City, Ho Chi Minh City, Viet Nam
– sequence: 3
  givenname: Thanh-Hoa
  surname: Vo
  fullname: Vo, Thanh-Hoa
  organization: School of Medicine, Vietnam National University Ho Chi Minh City, Ho Chi Minh City, Viet Nam
– sequence: 4
  givenname: Minh-Tri
  surname: Le
  fullname: Le, Minh-Tri
  organization: School of Medicine, Vietnam National University Ho Chi Minh City, Ho Chi Minh City, Viet Nam
– sequence: 5
  givenname: Viet-Khoa
  surname: Tran-Nguyen
  fullname: Tran-Nguyen, Viet-Khoa
  organization: Centre de Recherche en Cancérologie de Marseille (CRCM), Inserm, U1068, Marseille, France
– sequence: 6
  givenname: Thao Thanh
  surname: Vu
  fullname: Vu, Thao Thanh
  organization: Faculty of Pharmacy, University of Medicine and Pharmacy at Ho Chi Minh City, Ho Chi Minh City, Viet Nam
– sequence: 7
  givenname: Phuoc-Vinh
  surname: Nguyen
  fullname: Nguyen, Phuoc-Vinh
  email: npvinh@medvnu.edu.vn
  organization: School of Medicine, Vietnam National University Ho Chi Minh City, Ho Chi Minh City, Viet Nam
BackLink https://www.ncbi.nlm.nih.gov/pubmed/38179314$$D View this record in MEDLINE/PubMed
BookMark eNp9kUtvEzEQxy1URB_0GyC0Ry4Jfuz6cQGhCGilSnAArtasPZs4bLyLvYnUb4-TLVV74eLx4z-_Gc__kpzFISIhbxhdMsrk--2ynDf9tOSUi3JFZWNekAsuGr5QitVnT_bn5DrnLaWUNVw3vHlFzoVmyghWX5Df3xMeoMfosILoK5_26yrvs8NxCm3ow3RfDV3l-hCDg75aFVHwUOURXcBchVhFyMO4gXQf11gUDgorVSNMAeN0UvwKOEXYvSYvO-gzXj_EK_Lzy-cfq5vF3bevt6tPdwtXKzMtXOOYNqyscAxUKOa0Vh6ZAMoN7Wpea6nBtN5LVwvUXskWpaYgJW-8uCK3M9cPsLVjCrvSnB0g2NPFkNYW0hRcj1YxCp0WLTWuYLkEphwHpxg3BhuvCuvjzBr37Q69K19K0D-DPn-JYWPXw8EyqiRTShfCuwdCGv7sMU92F8p4-x4iDvtsueHaNFILXqT1LHVpyDlh91iHUXv03ZbuT77bo-929r2kvX3a42PSP5eL4MMswDL1Q8BkczGv2ORDQjeVsYT_V_gLiD3DYA
Cites_doi 10.1155/2017/1976273
10.1155/2018/3086586
10.1186/s12903-021-01721-x
10.1177/0956462414548906
10.3390/pathogens11111289
10.1136/pmj.78.922.455
10.4103/jcrt.JCRT_581_18
10.1111/myc.12330
10.1186/1471-2180-8-135
10.1093/mmy/myaa049
10.1007/s00203-015-1146-8
10.1128/AAC.41.7.1482
10.1128/IAI.67.10.5514-5517.1999
10.3390/life12111677
10.2147/IDR.S360973
10.1111/1567-1364.12042
10.1093/mmy/myz135
10.1093/mmy/myv085
10.1086/596757
10.1038/srep36157
10.1097/MAJ.0b013e3181f54dab
10.4103/0973-029X.141325
10.1002/1097-0142(19821215)50:12<2780::AID-CNCR2820501215>3.0.CO;2-P
10.1080/13693780601059936
10.1016/j.archger.2016.04.001
10.1007/s11046-012-9520-4
10.3390/data2030026
10.1128/JCM.38.8.3016-3021.2000
10.1128/AAC.00926-08
10.1038/nmeth.2019
10.1186/s12879-017-2916-5
10.1128/JCM.01811-20
10.1128/JCM.36.4.1157-1159.1998
ContentType Journal Article
Copyright 2023
2023 The Authors. Published by Elsevier B.V.
2023 The Authors. Published by Elsevier B.V. 2023
Copyright_xml – notice: 2023
– notice: 2023 The Authors. Published by Elsevier B.V.
– notice: 2023 The Authors. Published by Elsevier B.V. 2023
DBID 6I.
AAFTH
NPM
AAYXX
CITATION
7X8
5PM
DOA
DOI 10.1016/j.onehlt.2023.100659
DatabaseName ScienceDirect Open Access Titles
Elsevier:ScienceDirect:Open Access
PubMed
CrossRef
MEDLINE - Academic
PubMed Central (Full Participant titles)
Directory of Open Access Journals
DatabaseTitle PubMed
CrossRef
MEDLINE - Academic
DatabaseTitleList
PubMed

MEDLINE - Academic

Database_xml – sequence: 1
  dbid: DOA
  name: Directory of Open Access Journals
  url: http://www.doaj.org/
  sourceTypes: Open Website
DeliveryMethod fulltext_linktorsrc
Discipline Public Health
EISSN 2352-7714
EndPage 100659
ExternalDocumentID oai_doaj_org_article_710af83b09cf4226a17c2ac71299e5d7
10_1016_j_onehlt_2023_100659
38179314
S2352771423001799
Genre Journal Article
GroupedDBID .1-
.FO
0R~
0SF
1P~
457
53G
6I.
AACTN
AAEDW
AAFTH
AALRI
AAXUO
ABMAC
ACGFS
ADBBV
ADEZE
ADVLN
AEXQZ
AFRHN
AFTJW
AGHFR
AITUG
AJUYK
ALMA_UNASSIGNED_HOLDINGS
AMRAJ
AOIJS
BCNDV
EBS
EJD
FDB
GROUPED_DOAJ
HYE
IXB
KQ8
M~E
NCXOZ
O9-
OK1
ROL
RPM
SSZ
Z5R
AFJKZ
NPM
AAYXX
CITATION
7X8
5PM
ID FETCH-LOGICAL-c479t-c5c18915c1a89150371c887de13a0290f424868a9bdd6c43e8d76be680a6625d3
IEDL.DBID RPM
ISSN 2352-7714
IngestDate Tue Oct 22 15:00:35 EDT 2024
Tue Sep 17 21:29:00 EDT 2024
Sun Sep 29 07:21:46 EDT 2024
Thu Sep 26 21:01:15 EDT 2024
Sat Nov 02 12:11:04 EDT 2024
Sat Jul 27 15:42:08 EDT 2024
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Keywords ERG11
Candida species
Drug-resistance susceptibility
Antifungal agents
Language English
License This is an open access article under the CC BY-NC-ND license.
2023 The Authors. Published by Elsevier B.V.
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c479t-c5c18915c1a89150371c887de13a0290f424868a9bdd6c43e8d76be680a6625d3
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
OpenAccessLink https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10761778/
PMID 38179314
PQID 2928956832
PQPubID 23479
PageCount 1
ParticipantIDs doaj_primary_oai_doaj_org_article_710af83b09cf4226a17c2ac71299e5d7
pubmedcentral_primary_oai_pubmedcentral_nih_gov_10761778
proquest_miscellaneous_2928956832
crossref_primary_10_1016_j_onehlt_2023_100659
pubmed_primary_38179314
elsevier_sciencedirect_doi_10_1016_j_onehlt_2023_100659
PublicationCentury 2000
PublicationDate 2024-06-01
PublicationDateYYYYMMDD 2024-06-01
PublicationDate_xml – month: 06
  year: 2024
  text: 2024-06-01
  day: 01
PublicationDecade 2020
PublicationPlace Netherlands
PublicationPlace_xml – name: Netherlands
PublicationTitle One health
PublicationTitleAlternate One Health
PublicationYear 2024
Publisher Elsevier B.V
Elsevier
Publisher_xml – name: Elsevier B.V
– name: Elsevier
References Worthington, Eden, Clarkson (bb0190) 2004
Katz (bb0100) 2021; 1985
Castelo-Branco, Paiva, Teixeira, Caetano, Guedes, Cordeiro, Brilhante, Rocha, Sidrim (bb0110) 2020; 58
Paul, Kannan, Mohanram (bb0225) 2019; 5
Sanguinetti, Posteraro, Lass-Flörl (bb0195) 2015; 58
Xiang, Liu, Ni, Wang, Shi, Wei, Ni, Ge (bb0060) 2013; 13
Whaley, Berkow, Rybak, Nishimoto, Barker, Rogers (bb0055) 2016; 7
WHO TEAM (bb0030) 2022
Jain, Shah, Chandolia, Mathur, Chauhan, Chawda, Mosby, Bhagalia (bb0095) 2016; 10
Fraser, Brown, Houldsworth, Borman, Johnson (bb0175) 2015
Akpan, Morgan (bb0005) 2002; 78
Hamza, Matee, Moshi, Simon, Mugusi, Mikx, Helderman, Rijs, van der Ven, Verweij (bb0200) 2008; 8
White (bb0070) 1997; 41
Xu, Sheng, Zhao, Chen, Li (bb0230) 2015; 197
Rai, Misra, Panda, Sokolowski, Mishra, Das, Lapinska (bb0050) 2022; 12
DeGregorio, Lee, Ries (bb0090) 1982; 50
Fothergill (bb0120) 2012
Benito-Cruz, Aranda-Romo, López-Esqueda, de la Rosa-García, Rosas-Hernández, Sánchez-Vargas (bb0025) 2016; 65
Wahyuningsih, Freisleben, Sonntag, Schnitzler (bb0115) 2000; 38
Schindelin, Arganda-Carreras, Frise, Kaynig, Longair, Pietzsch, Preibisch, Rueden, Saalfeld, Schmid, Tinevez, White, Hartenstein, Eliceiri, Tomancak, Cardona (bb0130) 2012; 9
Quindós, Gil-Alonso, Marcos-Arias, Sevillano, Mateo, Jauregizar, Eraso (bb0040) 2019; 24
González Gravina, González de Morán, Zambrano, Lozano Chourio, Rodríguez de Valero, Robertis, Mesa (bb0180) 2007; 12
A.N. R, N.B. Rafiq (bb0035) 2022
Jayachandran, Katragadda, Thyagarajan, Vajravelu, Manikesi, Kaliappan, Jayachandran (bb0085) 2016; 2016
Singh, Verma, Murari, Agrawal (bb0010) 2014; 18
Gaitán-Cepeda, Sánchez-Vargas, Castillo (bb0075) 2015; 26
Černáková, Líšková, Lengyelová, Rodrigues (bb0020) 2022; 58
Talukdar, Barman, Sarma, Krishnatreya, Sharma, Kataki (bb0185) 2020; 16
Aslani, Janbabaei, Abastabar, Meis, Babaeian, Khodavaisy, Boekhout, Badali (bb0205) 2018; 18
Pappas, Kauffman, Andes, Benjamin, Calandra, Edwards, Filler, Fisher, Kullberg, Ostrosky-Zeichner, Reboli, Rex, Walsh, Sobel, Infectious Diseases Society of America (bb0045) 2009; 48
Borman, Fraser, Johnson (bb0135) 2021; 59
Mahdavi Omran, Rezaei Dastjerdi, Zuashkiani, Moqarabzadeh, Taghizadeh-Armaki (bb0215) 2018; 2018
Sonneborn, Bockmühl, Ernst (bb0145) 1999; 67
Matare, Nziramasanga, Gwanzura, Robertson (bb0140) 2017; 2017
Urbanek, Łapińska, Derkacz, Krasowska (bb0220) 2022; 11
Al-Yasiri, Normand, L’Ollivier, Lachaud, Bourgeois, Rebaudet, Piarroux, Mauffrey, Ranque (bb0105) 2016; 6
Ingle, Kodgire, Shiradhone, Patil, Zore (bb0150) 2017; 2
Merlino, Tambosis, Veal (bb0170) 1998; 36
Pincus, Orenga, Chatellier (bb0160) 2007; 45
Burton, Swiatlo, Shah (bb0165) 2011; 341
Taylor, Brizuela, Raja (bb0155) 2023
Borman, Johnson (bb0015) 2021; 59
(bb0125) 2018
Chitapanarux, Wongsrita, Sripan, Kongsupapsiri, Phakoetsuk, Chachvarat, Kittidachanan (bb0080) 2021; 21
Carvalhinho, Costa, Coelho, Martins, Sampaio (bb0210) 2012; 174
Odiba, Durojaye, Ezeonu, Mgbeahuruike, Nwanguma (bb0235) 2022; 15
Tsao, Rahkhoodaee, Raymond (bb0065) 2009; 53
DeGregorio (10.1016/j.onehlt.2023.100659_bb0090) 1982; 50
Al-Yasiri (10.1016/j.onehlt.2023.100659_bb0105) 2016; 6
Aslani (10.1016/j.onehlt.2023.100659_bb0205) 2018; 18
Merlino (10.1016/j.onehlt.2023.100659_bb0170) 1998; 36
Worthington (10.1016/j.onehlt.2023.100659_bb0190) 2004
Xu (10.1016/j.onehlt.2023.100659_bb0230) 2015; 197
Pappas (10.1016/j.onehlt.2023.100659_bb0045) 2009; 48
Pincus (10.1016/j.onehlt.2023.100659_bb0160) 2007; 45
Paul (10.1016/j.onehlt.2023.100659_bb0225) 2019; 5
Quindós (10.1016/j.onehlt.2023.100659_bb0040) 2019; 24
Castelo-Branco (10.1016/j.onehlt.2023.100659_bb0110) 2020; 58
Odiba (10.1016/j.onehlt.2023.100659_bb0235) 2022; 15
Katz (10.1016/j.onehlt.2023.100659_bb0100) 2021; 1985
Borman (10.1016/j.onehlt.2023.100659_bb0135) 2021; 59
Schindelin (10.1016/j.onehlt.2023.100659_bb0130) 2012; 9
Whaley (10.1016/j.onehlt.2023.100659_bb0055) 2016; 7
Borman (10.1016/j.onehlt.2023.100659_bb0015) 2021; 59
Wahyuningsih (10.1016/j.onehlt.2023.100659_bb0115) 2000; 38
Hamza (10.1016/j.onehlt.2023.100659_bb0200) 2008; 8
Fraser (10.1016/j.onehlt.2023.100659_bb0175) 2015
Gaitán-Cepeda (10.1016/j.onehlt.2023.100659_bb0075) 2015; 26
Burton (10.1016/j.onehlt.2023.100659_bb0165) 2011; 341
Akpan (10.1016/j.onehlt.2023.100659_bb0005) 2002; 78
Jayachandran (10.1016/j.onehlt.2023.100659_bb0085) 2016; 2016
Ingle (10.1016/j.onehlt.2023.100659_bb0150) 2017; 2
Rai (10.1016/j.onehlt.2023.100659_bb0050) 2022; 12
Matare (10.1016/j.onehlt.2023.100659_bb0140) 2017; 2017
González Gravina (10.1016/j.onehlt.2023.100659_bb0180) 2007; 12
Talukdar (10.1016/j.onehlt.2023.100659_bb0185) 2020; 16
Černáková (10.1016/j.onehlt.2023.100659_bb0020) 2022; 58
Chitapanarux (10.1016/j.onehlt.2023.100659_bb0080) 2021; 21
Mahdavi Omran (10.1016/j.onehlt.2023.100659_bb0215) 2018; 2018
White (10.1016/j.onehlt.2023.100659_bb0070) 1997; 41
Singh (10.1016/j.onehlt.2023.100659_bb0010) 2014; 18
Jain (10.1016/j.onehlt.2023.100659_bb0095) 2016; 10
Fothergill (10.1016/j.onehlt.2023.100659_bb0120) 2012
(10.1016/j.onehlt.2023.100659_bb0125) 2018
Sanguinetti (10.1016/j.onehlt.2023.100659_bb0195) 2015; 58
Tsao (10.1016/j.onehlt.2023.100659_bb0065) 2009; 53
WHO TEAM (10.1016/j.onehlt.2023.100659_bb0030)
Xiang (10.1016/j.onehlt.2023.100659_bb0060) 2013; 13
Sonneborn (10.1016/j.onehlt.2023.100659_bb0145) 1999; 67
A.N. R, N.B. Rafiq (10.1016/j.onehlt.2023.100659_bb0035) 2022
Urbanek (10.1016/j.onehlt.2023.100659_bb0220) 2022; 11
Taylor (10.1016/j.onehlt.2023.100659_bb0155) 2023
Benito-Cruz (10.1016/j.onehlt.2023.100659_bb0025) 2016; 65
Carvalhinho (10.1016/j.onehlt.2023.100659_bb0210) 2012; 174
References_xml – volume: 65
  start-page: 204
  year: 2016
  end-page: 210
  ident: bb0025
  article-title: Oral Candida isolates and fluconazole susceptibility patterns in older Mexican women
  publication-title: Arch. Gerontol. Geriatr.
  contributor:
    fullname: Sánchez-Vargas
– volume: 53
  start-page: 1344
  year: 2009
  end-page: 1352
  ident: bb0065
  article-title: Relative contributions of the
  publication-title: Antimicrob. Agents Chemother.
  contributor:
    fullname: Raymond
– volume: 59
  start-page: e01811
  year: 2021
  end-page: e01820
  ident: bb0015
  article-title: Name Changes for Fungi of Medical Importance, 2018 to 2019
  publication-title: J. Clin. Microbiol.
  contributor:
    fullname: Johnson
– volume: 341
  start-page: 71
  year: 2011
  end-page: 73
  ident: bb0165
  article-title: Misidentification of Candida parapsilosis as C famata in a clinical case of vertebral osteomyelitis
  publication-title: Am J Med Sci
  contributor:
    fullname: Shah
– volume: 58
  start-page: 896
  year: 2020
  end-page: 905
  ident: bb0110
  article-title: Azole resistance in Candida from animals calls for the one health approach to tackle the emergence of antimicrobial resistance
  publication-title: Med. Mycol.
  contributor:
    fullname: Sidrim
– volume: 24
  start-page: e172
  year: 2019
  end-page: e180
  ident: bb0040
  article-title: Therapeutic tools for oral candidiasis: current and new antifungal drugs
  publication-title: Med. Oral Patol. Oral Cir. Bucal.
  contributor:
    fullname: Eraso
– volume: 10
  start-page: ZC17
  year: 2016
  end-page: 20
  ident: bb0095
  article-title: The Oral carriage of Candida in Oral Cancer patients of Indian origin undergoing radiotherapy and/or chemotherapy
  publication-title: J. Clin. Diagn. Res. JCDR.
  contributor:
    fullname: Bhagalia
– volume: 2017
  start-page: 1
  year: 2017
  end-page: 5
  ident: bb0140
  article-title: Experimental germ tube induction in
  publication-title: Biomed. Res. Int.
  contributor:
    fullname: Robertson
– volume: 18
  start-page: S81
  year: 2014
  end-page: S85
  ident: bb0010
  article-title: Oral candidiasis: an overview
  publication-title: J. Oral Maxillofac. Pathol. JOMFP.
  contributor:
    fullname: Agrawal
– volume: 7
  start-page: 2173
  year: 2016
  ident: bb0055
  article-title: Azole antifungal resistance in Candida albicans and emerging non-albicans Candida species
  publication-title: Front. Microbiol.
  contributor:
    fullname: Rogers
– volume: 1985
  start-page: 714
  year: 2021
  end-page: 718
  ident: bb0100
  article-title: Prevalence of candidiasis and oral candidiasis in COVID-19 patients: a cross-sectional pilot study from the patients’ registry in a large health center
  publication-title: Quintessence Int. Berl. Ger.
  contributor:
    fullname: Katz
– year: 2018
  ident: bb0125
  article-title: M44: method for antifungal disk diffusion susceptibility testing of yeasts
  publication-title: Nielsen Bookdata, Place of Publication Not Identified
– volume: 58
  start-page: 2
  year: 2015
  end-page: 13
  ident: bb0195
  article-title: Antifungal drug resistance among
  publication-title: Mycoses.
  contributor:
    fullname: Lass-Flörl
– start-page: 65
  year: 2012
  end-page: 74
  ident: bb0120
  article-title: Antifungal susceptibility testing: Clinical laboratory and standards institute (CLSI) methods
  publication-title: Interact. Yeasts Moulds Antifung
  contributor:
    fullname: Fothergill
– volume: 13
  start-page: 386
  year: 2013
  end-page: 393
  ident: bb0060
  article-title: mutations associated with azole resistance in clinical isolates of
  publication-title: FEMS Yeast Res.
  contributor:
    fullname: Ge
– volume: 59
  start-page: 253
  year: 2021
  end-page: 258
  ident: bb0135
  article-title: CHROMagarTM Candida plus: a novel chromogenic agar that permits the rapid identification of Candida auris
  publication-title: Med. Mycol.
  contributor:
    fullname: Johnson
– volume: 12
  start-page: E419
  year: 2007
  end-page: E423
  ident: bb0180
  article-title: Oral candidiasis in children and adolescents with cancer. Identification of Candida spp
  publication-title: Med. Oral Patol. Oral Cir. Bucal.
  contributor:
    fullname: Mesa
– year: 2004
  ident: bb0190
  article-title: Interventions for preventing oral candidiasis for patients with cancer receiving treatment
  publication-title: The Cochrane Collaboration (Ed.), Cochrane Database Syst. Rev
  contributor:
    fullname: Clarkson
– volume: 12
  start-page: 1677
  year: 2022
  ident: bb0050
  article-title: Nystatin effectiveness in Oral candidiasis treatment: a Systematic Review & Meta-Analysis of clinical trials
  publication-title: Life.
  contributor:
    fullname: Lapinska
– year: 2022
  ident: bb0030
  article-title: WHO Fungal Priority Pathogens List to Guide Research, Development and Public Health Action
  contributor:
    fullname: WHO TEAM
– volume: 2016
  start-page: 8758461
  year: 2016
  ident: bb0085
  article-title: Oral candidiasis among Cancer patients attending a tertiary Care Hospital in Chennai, South India: an evaluation of Clinicomycological association and antifungal susceptibility pattern
  publication-title: Can. J. Infect. Dis. Med. Microbiol. J. Can. Mal. Infect. Microbiol. Medicale.
  contributor:
    fullname: Jayachandran
– volume: 78
  start-page: 455
  year: 2002
  end-page: 459
  ident: bb0005
  article-title: Oral candidiasis
  publication-title: Postgrad. Med. J.
  contributor:
    fullname: Morgan
– volume: 11
  start-page: 1289
  year: 2022
  ident: bb0220
  article-title: The role of ERG11 point mutations in the resistance of Candida albicans to fluconazole in the presence of lactate
  publication-title: Pathog. Basel Switz.
  contributor:
    fullname: Krasowska
– year: 2022
  ident: bb0035
  article-title: Candidiasis
  publication-title: StatPearls
  contributor:
    fullname: A.N. R, N.B. Rafiq
– volume: 8
  start-page: 135
  year: 2008
  ident: bb0200
  article-title: Species distribution and in vitro antifungal susceptibility of oral yeast isolates from Tanzanian HIV-infected patients with primary and recurrent oropharyngeal candidiasis
  publication-title: BMC Microbiol.
  contributor:
    fullname: Verweij
– volume: 18
  start-page: 24
  year: 2018
  ident: bb0205
  article-title: Identification of uncommon oral yeasts from cancer patients by MALDI-TOF mass spectrometry
  publication-title: BMC Infect. Dis.
  contributor:
    fullname: Badali
– volume: 38
  start-page: 3016
  year: 2000
  end-page: 3021
  ident: bb0115
  article-title: Simple and rapid detection of
  publication-title: J. Clin. Microbiol.
  contributor:
    fullname: Schnitzler
– volume: 67
  start-page: 5514
  year: 1999
  end-page: 5517
  ident: bb0145
  article-title: Chlamydospore formation in
  publication-title: Infect. Immun.
  contributor:
    fullname: Ernst
– volume: 9
  start-page: 676
  year: 2012
  end-page: 682
  ident: bb0130
  article-title: Fiji: an open-source platform for biological-image analysis
  publication-title: Nat. Methods
  contributor:
    fullname: Cardona
– volume: 58
  start-page: 576
  year: 2022
  ident: bb0020
  article-title: Prevalence and antifungal susceptibility profile of Oral Candida spp. isolates from a Hospital in Slovakia
  publication-title: Med. Kaunas Lith.
  contributor:
    fullname: Rodrigues
– year: 2023
  ident: bb0155
  article-title: Oral candidiasis
  publication-title: StatPearls
  contributor:
    fullname: Raja
– volume: 5
  start-page: 1
  year: 2019
  end-page: 6
  ident: bb0225
  article-title: Extensive ERG11 mutations associated with fluconazole-resistant Candida albicans isolated from HIV-infected patients
  publication-title: Curr. Med. Mycol.
  contributor:
    fullname: Mohanram
– volume: 21
  start-page: 353
  year: 2021
  ident: bb0080
  article-title: An underestimated pitfall of oral candidiasis in head and neck cancer patients undergoing radiotherapy: an observation study
  publication-title: BMC Oral Health
  contributor:
    fullname: Kittidachanan
– volume: 6
  start-page: 36157
  year: 2016
  ident: bb0105
  article-title: Opportunistic fungal pathogen Candida glabrata circulates between humans and yellow-legged gulls
  publication-title: Sci. Rep.
  contributor:
    fullname: Ranque
– start-page: myv085
  year: 2015
  ident: bb0175
  article-title: Rapid identification of 6328 isolates of pathogenic yeasts using MALDI-ToF MS and a simplified, rapid extraction procedure that is compatible with the Bruker Biotyper platform and database
  publication-title: Med. Mycol.
  contributor:
    fullname: Johnson
– volume: 50
  start-page: 2780
  year: 1982
  end-page: 2784
  ident: bb0090
  article-title: Candida infections in patients with acute leukemia: ineffectiveness of nystatin prophylaxis and relationship between oropharyngeal and systemic candidiasis
  publication-title: Cancer.
  contributor:
    fullname: Ries
– volume: 174
  start-page: 69
  year: 2012
  end-page: 76
  ident: bb0210
  article-title: Susceptibilities of Candida albicans mouth isolates to antifungal agents, essentials oils and mouth rinses
  publication-title: Mycopathologia.
  contributor:
    fullname: Sampaio
– volume: 41
  start-page: 1482
  year: 1997
  end-page: 1487
  ident: bb0070
  article-title: Increased mRNA levels of ERG16, CDR, and MDR1 correlate with increases in azole resistance in Candida albicans isolates from a patient infected with human immunodeficiency virus
  publication-title: Antimicrob. Agents Chemother.
  contributor:
    fullname: White
– volume: 16
  start-page: 209
  year: 2020
  ident: bb0185
  article-title: Fungal profile and antifungal susceptibility pattern of candidiasis in esophageal cancer patients
  publication-title: J. Cancer Res. Ther.
  contributor:
    fullname: Kataki
– volume: 2
  start-page: 26
  year: 2017
  ident: bb0150
  article-title: Chlamydospore specific proteins of Candida albicans
  publication-title: Data.
  contributor:
    fullname: Zore
– volume: 45
  start-page: 97
  year: 2007
  end-page: 121
  ident: bb0160
  article-title: Yeast identification – past, present, and future methods
  publication-title: Med. Mycol.
  contributor:
    fullname: Chatellier
– volume: 197
  start-page: 1087
  year: 2015
  end-page: 1093
  ident: bb0230
  article-title: ERG11 mutations and expression of resistance genes in fluconazole-resistant Candida albicans isolates
  publication-title: Arch. Microbiol.
  contributor:
    fullname: Li
– volume: 26
  start-page: 625
  year: 2015
  end-page: 632
  ident: bb0075
  article-title: Prevalence of oral candidiasis in HIV/AIDS children in highly active antiretroviral therapy era. A literature analysis
  publication-title: Int. J. STD AIDS
  contributor:
    fullname: Castillo
– volume: 2018
  start-page: 1
  year: 2018
  end-page: 6
  ident: bb0215
  article-title: In vitro antifungal susceptibility of
  publication-title: Biomed. Res. Int.
  contributor:
    fullname: Taghizadeh-Armaki
– volume: 36
  start-page: 1157
  year: 1998
  end-page: 1159
  ident: bb0170
  article-title: Chromogenic tube test for presumptive identification or confirmation of isolates as Candida albicans
  publication-title: J. Clin. Microbiol.
  contributor:
    fullname: Veal
– volume: 15
  start-page: 3111
  year: 2022
  end-page: 3133
  ident: bb0235
  article-title: A new variant of mutational and polymorphic signatures in the ERG11 gene of fluconazole-resistant Candida albicans
  publication-title: Infect. Drug Resist.
  contributor:
    fullname: Nwanguma
– volume: 48
  start-page: 503
  year: 2009
  end-page: 535
  ident: bb0045
  article-title: Clinical practice guidelines for the management of candidiasis: 2009 Update by the Infectious Diseases Society of America
  publication-title: Clin. Infect. Dis. Off. Publ. Infect. Dis. Soc. Am.
  contributor:
    fullname: Infectious Diseases Society of America
– volume: 2017
  start-page: 1
  year: 2017
  ident: 10.1016/j.onehlt.2023.100659_bb0140
  article-title: Experimental germ tube induction in Candida albicans : an evaluation of the effect of sodium bicarbonate on morphogenesis and comparison with pooled human serum
  publication-title: Biomed. Res. Int.
  doi: 10.1155/2017/1976273
  contributor:
    fullname: Matare
– volume: 2018
  start-page: 1
  year: 2018
  ident: 10.1016/j.onehlt.2023.100659_bb0215
  article-title: In vitro antifungal susceptibility of Candida species isolated from Iranian patients with denture stomatitis
  publication-title: Biomed. Res. Int.
  doi: 10.1155/2018/3086586
  contributor:
    fullname: Mahdavi Omran
– volume: 21
  start-page: 353
  year: 2021
  ident: 10.1016/j.onehlt.2023.100659_bb0080
  article-title: An underestimated pitfall of oral candidiasis in head and neck cancer patients undergoing radiotherapy: an observation study
  publication-title: BMC Oral Health
  doi: 10.1186/s12903-021-01721-x
  contributor:
    fullname: Chitapanarux
– year: 2018
  ident: 10.1016/j.onehlt.2023.100659_bb0125
  article-title: M44: method for antifungal disk diffusion susceptibility testing of yeasts
– volume: 5
  start-page: 1
  year: 2019
  ident: 10.1016/j.onehlt.2023.100659_bb0225
  article-title: Extensive ERG11 mutations associated with fluconazole-resistant Candida albicans isolated from HIV-infected patients
  publication-title: Curr. Med. Mycol.
  contributor:
    fullname: Paul
– volume: 10
  start-page: ZC17
  year: 2016
  ident: 10.1016/j.onehlt.2023.100659_bb0095
  article-title: The Oral carriage of Candida in Oral Cancer patients of Indian origin undergoing radiotherapy and/or chemotherapy
  publication-title: J. Clin. Diagn. Res. JCDR.
  contributor:
    fullname: Jain
– volume: 12
  start-page: E419
  year: 2007
  ident: 10.1016/j.onehlt.2023.100659_bb0180
  article-title: Oral candidiasis in children and adolescents with cancer. Identification of Candida spp
  publication-title: Med. Oral Patol. Oral Cir. Bucal.
  contributor:
    fullname: González Gravina
– year: 2022
  ident: 10.1016/j.onehlt.2023.100659_bb0035
  article-title: Candidiasis
  contributor:
    fullname: A.N. R, N.B. Rafiq
– volume: 26
  start-page: 625
  year: 2015
  ident: 10.1016/j.onehlt.2023.100659_bb0075
  article-title: Prevalence of oral candidiasis in HIV/AIDS children in highly active antiretroviral therapy era. A literature analysis
  publication-title: Int. J. STD AIDS
  doi: 10.1177/0956462414548906
  contributor:
    fullname: Gaitán-Cepeda
– volume: 11
  start-page: 1289
  year: 2022
  ident: 10.1016/j.onehlt.2023.100659_bb0220
  article-title: The role of ERG11 point mutations in the resistance of Candida albicans to fluconazole in the presence of lactate
  publication-title: Pathog. Basel Switz.
  doi: 10.3390/pathogens11111289
  contributor:
    fullname: Urbanek
– volume: 78
  start-page: 455
  year: 2002
  ident: 10.1016/j.onehlt.2023.100659_bb0005
  article-title: Oral candidiasis
  publication-title: Postgrad. Med. J.
  doi: 10.1136/pmj.78.922.455
  contributor:
    fullname: Akpan
– volume: 16
  start-page: 209
  year: 2020
  ident: 10.1016/j.onehlt.2023.100659_bb0185
  article-title: Fungal profile and antifungal susceptibility pattern of candidiasis in esophageal cancer patients
  publication-title: J. Cancer Res. Ther.
  doi: 10.4103/jcrt.JCRT_581_18
  contributor:
    fullname: Talukdar
– volume: 58
  start-page: 2
  year: 2015
  ident: 10.1016/j.onehlt.2023.100659_bb0195
  article-title: Antifungal drug resistance among Candida species: mechanisms and clinical impact
  publication-title: Mycoses.
  doi: 10.1111/myc.12330
  contributor:
    fullname: Sanguinetti
– volume: 8
  start-page: 135
  year: 2008
  ident: 10.1016/j.onehlt.2023.100659_bb0200
  article-title: Species distribution and in vitro antifungal susceptibility of oral yeast isolates from Tanzanian HIV-infected patients with primary and recurrent oropharyngeal candidiasis
  publication-title: BMC Microbiol.
  doi: 10.1186/1471-2180-8-135
  contributor:
    fullname: Hamza
– volume: 59
  start-page: 253
  year: 2021
  ident: 10.1016/j.onehlt.2023.100659_bb0135
  article-title: CHROMagarTM Candida plus: a novel chromogenic agar that permits the rapid identification of Candida auris
  publication-title: Med. Mycol.
  doi: 10.1093/mmy/myaa049
  contributor:
    fullname: Borman
– volume: 197
  start-page: 1087
  year: 2015
  ident: 10.1016/j.onehlt.2023.100659_bb0230
  article-title: ERG11 mutations and expression of resistance genes in fluconazole-resistant Candida albicans isolates
  publication-title: Arch. Microbiol.
  doi: 10.1007/s00203-015-1146-8
  contributor:
    fullname: Xu
– start-page: 65
  year: 2012
  ident: 10.1016/j.onehlt.2023.100659_bb0120
  article-title: Antifungal susceptibility testing: Clinical laboratory and standards institute (CLSI) methods
  contributor:
    fullname: Fothergill
– year: 2023
  ident: 10.1016/j.onehlt.2023.100659_bb0155
  article-title: Oral candidiasis
  contributor:
    fullname: Taylor
– volume: 41
  start-page: 1482
  year: 1997
  ident: 10.1016/j.onehlt.2023.100659_bb0070
  article-title: Increased mRNA levels of ERG16, CDR, and MDR1 correlate with increases in azole resistance in Candida albicans isolates from a patient infected with human immunodeficiency virus
  publication-title: Antimicrob. Agents Chemother.
  doi: 10.1128/AAC.41.7.1482
  contributor:
    fullname: White
– volume: 67
  start-page: 5514
  year: 1999
  ident: 10.1016/j.onehlt.2023.100659_bb0145
  article-title: Chlamydospore formation in Candida albicans requires the Efg1p morphogenetic regulator
  publication-title: Infect. Immun.
  doi: 10.1128/IAI.67.10.5514-5517.1999
  contributor:
    fullname: Sonneborn
– volume: 12
  start-page: 1677
  year: 2022
  ident: 10.1016/j.onehlt.2023.100659_bb0050
  article-title: Nystatin effectiveness in Oral candidiasis treatment: a Systematic Review & Meta-Analysis of clinical trials
  publication-title: Life.
  doi: 10.3390/life12111677
  contributor:
    fullname: Rai
– volume: 15
  start-page: 3111
  year: 2022
  ident: 10.1016/j.onehlt.2023.100659_bb0235
  article-title: A new variant of mutational and polymorphic signatures in the ERG11 gene of fluconazole-resistant Candida albicans
  publication-title: Infect. Drug Resist.
  doi: 10.2147/IDR.S360973
  contributor:
    fullname: Odiba
– ident: 10.1016/j.onehlt.2023.100659_bb0030
  contributor:
    fullname: WHO TEAM
– volume: 13
  start-page: 386
  year: 2013
  ident: 10.1016/j.onehlt.2023.100659_bb0060
  article-title: Erg11 mutations associated with azole resistance in clinical isolates of Candida albicans
  publication-title: FEMS Yeast Res.
  doi: 10.1111/1567-1364.12042
  contributor:
    fullname: Xiang
– volume: 58
  start-page: 896
  year: 2020
  ident: 10.1016/j.onehlt.2023.100659_bb0110
  article-title: Azole resistance in Candida from animals calls for the one health approach to tackle the emergence of antimicrobial resistance
  publication-title: Med. Mycol.
  doi: 10.1093/mmy/myz135
  contributor:
    fullname: Castelo-Branco
– start-page: myv085
  year: 2015
  ident: 10.1016/j.onehlt.2023.100659_bb0175
  article-title: Rapid identification of 6328 isolates of pathogenic yeasts using MALDI-ToF MS and a simplified, rapid extraction procedure that is compatible with the Bruker Biotyper platform and database
  publication-title: Med. Mycol.
  doi: 10.1093/mmy/myv085
  contributor:
    fullname: Fraser
– volume: 48
  start-page: 503
  year: 2009
  ident: 10.1016/j.onehlt.2023.100659_bb0045
  article-title: Clinical practice guidelines for the management of candidiasis: 2009 Update by the Infectious Diseases Society of America
  publication-title: Clin. Infect. Dis. Off. Publ. Infect. Dis. Soc. Am.
  doi: 10.1086/596757
  contributor:
    fullname: Pappas
– year: 2004
  ident: 10.1016/j.onehlt.2023.100659_bb0190
  article-title: Interventions for preventing oral candidiasis for patients with cancer receiving treatment
  contributor:
    fullname: Worthington
– volume: 6
  start-page: 36157
  year: 2016
  ident: 10.1016/j.onehlt.2023.100659_bb0105
  article-title: Opportunistic fungal pathogen Candida glabrata circulates between humans and yellow-legged gulls
  publication-title: Sci. Rep.
  doi: 10.1038/srep36157
  contributor:
    fullname: Al-Yasiri
– volume: 341
  start-page: 71
  year: 2011
  ident: 10.1016/j.onehlt.2023.100659_bb0165
  article-title: Misidentification of Candida parapsilosis as C famata in a clinical case of vertebral osteomyelitis
  publication-title: Am J Med Sci
  doi: 10.1097/MAJ.0b013e3181f54dab
  contributor:
    fullname: Burton
– volume: 18
  start-page: S81
  year: 2014
  ident: 10.1016/j.onehlt.2023.100659_bb0010
  article-title: Oral candidiasis: an overview
  publication-title: J. Oral Maxillofac. Pathol. JOMFP.
  doi: 10.4103/0973-029X.141325
  contributor:
    fullname: Singh
– volume: 50
  start-page: 2780
  year: 1982
  ident: 10.1016/j.onehlt.2023.100659_bb0090
  article-title: Candida infections in patients with acute leukemia: ineffectiveness of nystatin prophylaxis and relationship between oropharyngeal and systemic candidiasis
  publication-title: Cancer.
  doi: 10.1002/1097-0142(19821215)50:12<2780::AID-CNCR2820501215>3.0.CO;2-P
  contributor:
    fullname: DeGregorio
– volume: 45
  start-page: 97
  year: 2007
  ident: 10.1016/j.onehlt.2023.100659_bb0160
  article-title: Yeast identification – past, present, and future methods
  publication-title: Med. Mycol.
  doi: 10.1080/13693780601059936
  contributor:
    fullname: Pincus
– volume: 7
  start-page: 2173
  year: 2016
  ident: 10.1016/j.onehlt.2023.100659_bb0055
  article-title: Azole antifungal resistance in Candida albicans and emerging non-albicans Candida species
  publication-title: Front. Microbiol.
  contributor:
    fullname: Whaley
– volume: 2016
  start-page: 8758461
  year: 2016
  ident: 10.1016/j.onehlt.2023.100659_bb0085
  article-title: Oral candidiasis among Cancer patients attending a tertiary Care Hospital in Chennai, South India: an evaluation of Clinicomycological association and antifungal susceptibility pattern
  publication-title: Can. J. Infect. Dis. Med. Microbiol. J. Can. Mal. Infect. Microbiol. Medicale.
  contributor:
    fullname: Jayachandran
– volume: 65
  start-page: 204
  year: 2016
  ident: 10.1016/j.onehlt.2023.100659_bb0025
  article-title: Oral Candida isolates and fluconazole susceptibility patterns in older Mexican women
  publication-title: Arch. Gerontol. Geriatr.
  doi: 10.1016/j.archger.2016.04.001
  contributor:
    fullname: Benito-Cruz
– volume: 174
  start-page: 69
  year: 2012
  ident: 10.1016/j.onehlt.2023.100659_bb0210
  article-title: Susceptibilities of Candida albicans mouth isolates to antifungal agents, essentials oils and mouth rinses
  publication-title: Mycopathologia.
  doi: 10.1007/s11046-012-9520-4
  contributor:
    fullname: Carvalhinho
– volume: 2
  start-page: 26
  year: 2017
  ident: 10.1016/j.onehlt.2023.100659_bb0150
  article-title: Chlamydospore specific proteins of Candida albicans
  publication-title: Data.
  doi: 10.3390/data2030026
  contributor:
    fullname: Ingle
– volume: 1985
  start-page: 714
  issue: 52
  year: 2021
  ident: 10.1016/j.onehlt.2023.100659_bb0100
  article-title: Prevalence of candidiasis and oral candidiasis in COVID-19 patients: a cross-sectional pilot study from the patients’ registry in a large health center
  publication-title: Quintessence Int. Berl. Ger.
  contributor:
    fullname: Katz
– volume: 24
  start-page: e172
  year: 2019
  ident: 10.1016/j.onehlt.2023.100659_bb0040
  article-title: Therapeutic tools for oral candidiasis: current and new antifungal drugs
  publication-title: Med. Oral Patol. Oral Cir. Bucal.
  contributor:
    fullname: Quindós
– volume: 38
  start-page: 3016
  year: 2000
  ident: 10.1016/j.onehlt.2023.100659_bb0115
  article-title: Simple and rapid detection of Candida albicans DNA in serum by PCR for diagnosis of invasive candidiasis
  publication-title: J. Clin. Microbiol.
  doi: 10.1128/JCM.38.8.3016-3021.2000
  contributor:
    fullname: Wahyuningsih
– volume: 53
  start-page: 1344
  year: 2009
  ident: 10.1016/j.onehlt.2023.100659_bb0065
  article-title: Relative contributions of the Candida albicans ABC transporters Cdr1p and Cdr2p to clinical azole resistance
  publication-title: Antimicrob. Agents Chemother.
  doi: 10.1128/AAC.00926-08
  contributor:
    fullname: Tsao
– volume: 9
  start-page: 676
  year: 2012
  ident: 10.1016/j.onehlt.2023.100659_bb0130
  article-title: Fiji: an open-source platform for biological-image analysis
  publication-title: Nat. Methods
  doi: 10.1038/nmeth.2019
  contributor:
    fullname: Schindelin
– volume: 18
  start-page: 24
  year: 2018
  ident: 10.1016/j.onehlt.2023.100659_bb0205
  article-title: Identification of uncommon oral yeasts from cancer patients by MALDI-TOF mass spectrometry
  publication-title: BMC Infect. Dis.
  doi: 10.1186/s12879-017-2916-5
  contributor:
    fullname: Aslani
– volume: 58
  start-page: 576
  year: 2022
  ident: 10.1016/j.onehlt.2023.100659_bb0020
  article-title: Prevalence and antifungal susceptibility profile of Oral Candida spp. isolates from a Hospital in Slovakia
  publication-title: Med. Kaunas Lith.
  contributor:
    fullname: Černáková
– volume: 59
  start-page: e01811
  year: 2021
  ident: 10.1016/j.onehlt.2023.100659_bb0015
  article-title: Name Changes for Fungi of Medical Importance, 2018 to 2019
  publication-title: J. Clin. Microbiol.
  doi: 10.1128/JCM.01811-20
  contributor:
    fullname: Borman
– volume: 36
  start-page: 1157
  year: 1998
  ident: 10.1016/j.onehlt.2023.100659_bb0170
  article-title: Chromogenic tube test for presumptive identification or confirmation of isolates as Candida albicans
  publication-title: J. Clin. Microbiol.
  doi: 10.1128/JCM.36.4.1157-1159.1998
  contributor:
    fullname: Merlino
SSID ssj0001528525
Score 2.332001
Snippet In the nature, Candida species are normal inhabitants and can be observed in a wide variety of vertebrates. In humans, especially for cancer patients who fall...
In the nature, species are normal inhabitants and can be observed in a wide variety of vertebrates. In humans, especially for cancer patients who fall prey to...
In the nature, Candida species are normal inhabitants and can be observed in a wide variety of vertebrates. In humans, especially for cancer patients who fall...
SourceID doaj
pubmedcentral
proquest
crossref
pubmed
elsevier
SourceType Open Website
Open Access Repository
Aggregation Database
Index Database
Publisher
StartPage 100659
SubjectTerms Antifungal agents
Candida species
Drug-resistance susceptibility
ERG11
Research Paper
SummonAdditionalLinks – databaseName: Directory of Open Access Journals
  dbid: DOA
  link: http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV25btwwECUSVwGCIHcUJwEDpBUiUhKP0idcpcmBdMTwkL05uMbuqvDfm0NKi924cJNGAiRCIjlDzZB675GQT975MLTa1mxwou7awGptFauHIUgVrHJ9Fnu--Cq__FSnZyiTs93qCzFhRR64dNznFAFhUK1ttBuQ9QlMOg5OpjilQ-8Lj7yRO5Opwg_mquf9zJXLgK5lDFd_ED7JW8QGCJQn3YlFWbJ_LyTdTTn_RU7uhKLzp-TJlEPSo1L3Z-RBiM_J47IARwuv6AX5jeJMkClFFKKnfjVe0vW4zjCWjIi9ocuBzsxIeoL8Fg8UqZdp9kwXkUbAPQ5gdRMv00OpQwdZ0UmJNZf4sQibCH9fku_nZ99OLuppZ4XadVJvatc7pjRLR8ATyva59LXxgbXQcN2knu6UUKCt98IlCyovhQ1CNSDShMm3r8hBTP35htCU8KkgNChofDfIDjiHHry2om0sZ7Yi9dzH5roIaJgZWfbLFJsYtIkpNqnIMRpiWxblr_OF5BRmcgpzn1NURM5mNFMmUTKE9KjFPa__OFvdpIGGf08ghuW4NlynuWkv0hewIq-LF2wriTKHumVdRdSef-y1Yv9OXFxlMW-GC0lSqrf_o92H5FFqS1egbO_IwWY1hvfk4dqPH_L4uAXTXhb5
  priority: 102
  providerName: Directory of Open Access Journals
Title Prevalence and drug susceptibility of clinical Candida species in nasopharyngeal cancer patients in Vietnam
URI https://dx.doi.org/10.1016/j.onehlt.2023.100659
https://www.ncbi.nlm.nih.gov/pubmed/38179314
https://search.proquest.com/docview/2928956832
https://pubmed.ncbi.nlm.nih.gov/PMC10761778
https://doaj.org/article/710af83b09cf4226a17c2ac71299e5d7
Volume 18
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Jj9MwFLbonJAQYicsIyNxzTR2Ei9HKDOaCwixCXGxnpd0AlN3lDaH-fd4aUYtHJC4JFLiOLHfi_1e8n2fEXptjXVdLXVJOsPKpnaklFqQsuscF04L0yax5_PP_MN38e40yuSwiQuTQPtG9yf-cnXi-4uErbxamfmEE5t_fL8gMfnmXMxnaBaCw70cPXODqWhpO_HkEphr7d3FZYRO0jriAliUJt2bh5Jc_8F09He4-Sdqcm8aOruH7u7iR_wmP-d9dMv5B-hO_viGM6foIfoVhZkg0YkweIvtMC7xZtwkCEtCw17jdYcnViReRG6LBRxplyFzxr3HHuL6BjBc-2WoFJvoHAPeqbCmEt96t_WweoS-np1-WZyXu1UVStNwuS1Na4iQJGwh7qJknwkjjXWkhorKqmtoI5gAqa1lJlhPWM60Y6ICFpIlWz9GRz7051OEQ7AnHJMgoLJNxxugFFqwUrO60pToApVTH6urLJ6hJlTZT5VtoqJNVLZJgd5GQ9yUjdLX6cB6WKqdA6gQEkEnal1J00UaMBBuKBgeAhfpWssLxCczql0UkaODUFX_j9u_mqyuwksW_5yAd-txo6gMeWnLwuhXoCfZC24eMkocypo0BRIH_nHQisMzwa-TkPfkx8_-_9Ln6HZoQZPBay_Q0XYY3Us029jxOH1eOE7vRtj-aD_9BlDuGHM
link.rule.ids 230,315,729,782,786,866,887,2107,27934,27935,53802,53804
linkProvider National Library of Medicine
linkToHtml http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Jb9QwFLZoOYCEyloaViNxTSd2Ei9HGFoNoq2QKIib5S3TQMdTZSaH_nu8JNUMHJB6SaTYWZz3bL-XfN9nAN4bbWxTcpWjRpO8Ki3KuWIobxpLmVVM11HsefaNnv1kn46CTA4ZuTARtK9Ve-guF4euvYjYyquFnow4scnX0ykKyTelbLID7voOW-CNLD2xgzGrcT0y5SKca-nsxWUAT-IyIANIECfdmImiYP_WhPRvwPk3bnJjIjp-eNsmPAJ7Q-gJP6Tyx-COdU_Ag_TdDiY60lPwO2g6ychEgtIZaLp-Dlf9KqJfIpD2Gi4bOBIq4TTQYoyEgbHpk27YOuhkWBpBdtdu7i8KdfCrDg4CrrHGj9aunVw8A9-Pj86ns3xYkCHXFeXrXNcaMY78VoZdUPvTfpAyFpWywLxoKlwxwiRXxhDtDc8MJcoSVkji8yxT7oNd5w1xAKCPE5klXDJZmKqhlcRY1tJwRcpCYaQykI_GEVdJd0OMgLRfIhlTBGOKZMwMfAwWvKkbVLPjgWU3F8OLFz6akg0rVcF1ExjEElGNpaY-5uG2NjQDdLS_GAKQFFj4S7X_uf270V2E75_hp4t0dtmvBOY-pa2JHzgz8Dy5z81DBnVEXqIqA2zLsbZasV3i_SlqgI_-8-L2p74F92bnpyfi5PPZl5fgvm9NlTBwr8Duuuvta7CzMv2b2LX-AGoXLDw
linkToPdf http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1Jb9QwFLZokRASYi-E1Uhc04mdxAs3mHZUBFSVWMTN8joNdDyjzOTQf4_tJNUMHJDgkkiJ48R5z_Z7yfd9BuC10ca6kqscOU3yqrQo54qh3DlLmVVM10ns-eQzPf3Ojo6jTM6bkQuTQPtaNYf-YnHom_OErVwt9GTEiU3OPk1RTL4pZZOVcZM9cD102qLaytR7hjBmNa5HtlyCdC29Pb-IAEpcRnQAiQKlW7NREu3fmZT-DDp_x05uTUazO__TjLvg9hCCwrd9mXvgmvX3wa3--x3saUkPwM-o7SQTIwlKb6Bpuzlcd-uEgkmA2ku4dHAkVsJppMcYCSNzMyTfsPHQy7hEgmwv_TxUCnX0rxYOQq6pxLfGbrxcPARfZ8dfpif5sDBDrivKN7muNWIcha2Mu6j6p8NgZSwqZYF54SpcMcIkV8YQHRyAGUqUJayQJORbpjwA-z4Y4zGAIV5klnDJZGEqRyuJsayl4YqUhcJIZSAfDSRWvf6GGIFpP0RvUBENKnqDZuBdtOJV2aienQ4s27kYXr4IUZV0rFQF1y4yiSWiGktNQ-zDbW1oBujoA2IIRPoAI1TV_OX2r0aXEaGfxp8v0ttltxaYh9S2JmEAzcCj3oWuHjKqJPISVRlgO86104rdM8Gnkhb46ENP_v3Sl-DG2dFMfHx_-uEpuBkaU_VQuGdgf9N29jnYW5vuRepdvwC8bi68
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Prevalence+and+drug+susceptibility+of+clinical+Candida+species+in+nasopharyngeal+cancer+patients+in+Vietnam&rft.jtitle=One+health&rft.au=Nguyen%2C+Bac+V.G.&rft.au=Nguyen%2C+Hau+H.N.&rft.au=Vo%2C+Thanh-Hoa&rft.au=Le%2C+Minh-Tri&rft.date=2024-06-01&rft.pub=Elsevier+B.V&rft.issn=2352-7714&rft.eissn=2352-7714&rft.volume=18&rft_id=info:doi/10.1016%2Fj.onehlt.2023.100659&rft.externalDocID=S2352771423001799
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2352-7714&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2352-7714&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2352-7714&client=summon